Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
290 GBX | -4.61% | +7.41% | +2.47% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Sales 2024 * | 681M 931M | Sales 2025 * | 836M 1.14B | Capitalization | 3.08B 4.21B |
---|---|---|---|---|---|
Net income 2024 * | -109M -149M | Net income 2025 * | -6M -8.2M | EV / Sales 2024 * | 4.23 x |
Net cash position 2024 * | 199M 271M | Net cash position 2025 * | 306M 418M | EV / Sales 2025 * | 3.32 x |
P/E ratio 2024 * |
-26.7
x | P/E ratio 2025 * |
561
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.37% |
Latest transcript on HUTCHMED (China) Limited
1 day | -4.61% | ||
1 week | +7.41% | ||
Current month | +8.41% | ||
1 month | +9.85% | ||
3 months | +41.81% | ||
6 months | +3.20% | ||
Current year | +2.47% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 99-12-31 |
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
BRD | Director/Board Member | 70 | 16-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 290 | -4.61% | 117,319 |
24-04-25 | 304 | +2.70% | 204,831 |
24-04-24 | 296 | +2.07% | 53,971 |
24-04-23 | 290 | +5.07% | 302,868 |
24-04-22 | 276 | +2.22% | 253,307 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.47% | 3.08B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- HCM Stock